Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (91-100 of 306) with videos related to

Pageof 31
Sort By:
Oncology|October 23, 2022
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting AntiviralsNorio Akuta, Hitomi Sezaki, Shunichiro Fujiyama, et al.
Oncology|June 14, 2014
Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov modelKenji Ikeda, Yusuke Kawamura, Masahiro Kobayashi, et al.
Journal of Medical Virology|April 20, 2011
Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapyNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Journal of Gastroenterology|February 29, 2012
Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infectionNami Mori, Fumitaka Suzuki, Yusuke Kawamura, et al.
Internal Medicine (Tokyo, Japan)|October 2, 2008
Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patientsMiharu Hirakawa, Kenji Ikeda, Yasuji Arase, et al.
BMC Gastroenterology|November 8, 2018
Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in JapanNorio Akuta, Yusuke Kawamura, Yasuji Arase, et al.
Journal of Clinical Microbiology|November 2, 2018
Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus ClearanceNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.
Intervirology|December 14, 2006
Long-term outcome after interferon therapy in elderly patients with chronic hepatitis CYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
BMC Gastroenterology|April 24, 2021
Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort studyShunichiro Fujiyama, Norio Akuta, Hitomi Sezaki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2008
Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinomaTetsuya Hosaka, Kenji Ikeda, Masahiro Kobayashi, et al.
Pageof 31

Showing results (91-100 of 306) with videos related to

Sort By:
Pageof 31
Oncology|October 23, 2022
Simple Predictive Markers and Clinicopathological Features of Primary Liver Cancer following HCV Clearance with Direct-Acting AntiviralsNorio Akuta, Hitomi Sezaki, Shunichiro Fujiyama, et al.
Oncology|June 14, 2014
Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov modelKenji Ikeda, Yusuke Kawamura, Masahiro Kobayashi, et al.
Journal of Medical Virology|April 20, 2011
Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapyNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Journal of Gastroenterology|February 29, 2012
Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infectionNami Mori, Fumitaka Suzuki, Yusuke Kawamura, et al.
Internal Medicine (Tokyo, Japan)|October 2, 2008
Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patientsMiharu Hirakawa, Kenji Ikeda, Yasuji Arase, et al.
BMC Gastroenterology|November 8, 2018
Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in JapanNorio Akuta, Yusuke Kawamura, Yasuji Arase, et al.
Journal of Clinical Microbiology|November 2, 2018
Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus ClearanceNorio Akuta, Fumitaka Suzuki, Hitomi Sezaki, et al.
Intervirology|December 14, 2006
Long-term outcome after interferon therapy in elderly patients with chronic hepatitis CYasuji Arase, Kenji Ikeda, Fumitaka Suzuki, et al.
BMC Gastroenterology|April 24, 2021
Mortality rates and risk factors in 1412 Japanese patients with decompensated hepatitis C virus-related cirrhosis: a retrospective long-term cohort studyShunichiro Fujiyama, Norio Akuta, Hitomi Sezaki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2008
Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinomaTetsuya Hosaka, Kenji Ikeda, Masahiro Kobayashi, et al.
Pageof 31